![](/img/cover-not-exists.png)
44PGlobal clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab
Zhang, Q, Xu, B, Zhang, Q, Sun, T, Li, W, Teng, Y, Hu, X, Bondarenko, I, Adamchuk, H, Zhang, L, Trukhin, D, Wang, S, Zheng, H, Tong, Z, Zhang, X, Liu, E, Jiang, W, Liu, S, Luk, AVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy428.005
Date:
November, 2018
File:
PDF, 82 KB
2018